Mayne Pharma (MAYNF, $2.85) lost -3 over the last three months. By comparison, the broader Pharmaceuticals: Major Industry returned over the same period. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry over the last three months, and found that of them (5) exhibited an Uptrend while of them (4) experienced a Downtrend.